ESC 365 - Prolonged P2Y12 inhibition or Factor Xa inhibition in patients after an acute coronary syndrome

ESC Premium Access

Prolonged P2Y12 inhibition or Factor Xa inhibition in patients after an acute coronary syndrome

Session: Innovative strategies for secondary prevention

Topic: Treatment

Speaker: Doctor T. Cuisset (Marseille, FR)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Thomas Cuisset

Hospital La Timone of Marseille, Marseille (France)

4 presentations

1 follower

3 more presentations in this session

Innovative strategies for lipid lowering treatment: PCSK9 inhibition

Speaker: Professor F. Mach (Geneva, CH)

Anti-inflammatory therapy : interleukin-1 beta inhibition to prevent cardiovascular events

Speaker: Doctor P. Ridker (Boston, US)

Balancing residual inflammatory, lipid, and thrombotic risk in coronary artery disease

Speaker: Professor P. Libby (Boston, US)

Access the full session

Innovative strategies for secondary prevention

Speakers: Doctor T. Cuisset, Professor F. Mach, Doctor P. Ridker, Professor P. Libby

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources